Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 7:17 AM ET


Company Overview of CellGenTech, Inc.

Company Overview

CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine/technology for the development of gene/cell therapies. The company provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; and arteriosclerotic disease, and cancer or degenerative neuropathies. CellGenTech, Inc. was founded in 2003 and is based in Chiba, Japan.

Chiba-dai Inohana Innovation Plaza #101

1-8-15, Inohana


Chiba,  260-0856


Founded in 2003


81 434 41 4121


81 434 41 4121

Key Executives for CellGenTech, Inc.

Founder, Chief Executive Officer and President
Senior Director of Business Development
Senior Director of Clinical Development
Senior Director of Pharmaceutical Affairs and Auditor
Senior Director of Clinical Development and Auditor
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Preventec, Inc. Asia
Olympus Terumo Biomaterials Corp. Asia
Gene Medicine Japan, Inc. Asia
MediciNova Japan Inc. Asia
iGENE Therapeutics, Inc. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CellGenTech, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at